MCID: FTT003
MIFTS: 39

Fatty Acid Oxidation Disorders malady

Genetic diseases (common) category

Aliases & Classifications for Fatty Acid Oxidation Disorders

About this section

Aliases & Descriptions for Fatty Acid Oxidation Disorders:

Name: Fatty Acid Oxidation Disorders 20


Classifications:



Summaries for Fatty Acid Oxidation Disorders

About this section
MalaCards based summary: Fatty Acid Oxidation Disorders is related to organic acidemia and acyl-coa dehydrogenase, short-chain, deficiency of. An important gene associated with Fatty Acid Oxidation Disorders is CPT2 (carnitine palmitoyltransferase 2), and among its related pathways are beta-Alanine metabolism and Beta oxidation of octanoyl-CoA to hexanoyl-CoA. The compounds Methacrylyl-CoA and Tiglyl-CoA have been mentioned in the context of this disorder. Affiliated tissues include liver, skin and whole blood, and related mouse phenotypes are adipose tissue and muscle.

Related Diseases for Fatty Acid Oxidation Disorders

About this section

Diseases related to Fatty Acid Oxidation Disorders via text searches within MalaCards or GeneCards Suite gene sharing:

(show all 35)
idRelated DiseaseScoreTop Affiliating Genes
1organic acidemia31.1ACADM, ACADS
2acyl-coa dehydrogenase, short-chain, deficiency of30.8ACADM, ACADS
3d-bifunctional protein deficiency30.6SCP2, HSD17B4
4sudden infant death syndrome30.3HADHA, ACADS, ACADVL, ACADM, SLC25A20
53-hydroxyacyl-coa dehydrogenase deficiency10.4
6liver disease10.4
7mitochondrial trifunctional protein deficiency10.4
8myoglobinuria recurrent10.4ACADVL, CPT2
9carnitine palmitoyltransferase ii deficiency10.3CPT1A, CPT2
10abetalipoproteinemia10.3HADHA, CPT2
11spinocerebellar ataxia10.3SLC25A20, ACADM
12phenylketonuria10.3ACADM, HADHA
13congenital adrenal hyperplasia10.2ACADM, HADHA
14carnitine deficiency, systemic primary10.2ACADVL, ACADS, CPT2
15trifunctional protein deficiency10.2
16carnitine-acylcarnitine translocase deficiency10.2
17hellp syndrome10.2
18reye syndrome10.2
19cyclic vomiting syndrome10.2
20mitochondrial disorders10.2CPT2, SLC25A20
21hypoalphalipoproteinemia10.2PPARA
22rhizomelic chondrodysplasia punctata, type 110.2SCP2, HSD17B4
23rhizomelic chondrodysplasia punctata10.1SCP2, HSD17B4
24galactosemia10.1SLC25A13, ACADVL
25hyperammonemia multi-gene panels10.1SLC25A13, SLC25A20, ACADS
26noonan syndrome 110.0HADHA, CPT2, ACADVL, ACADM, SLC25A20
27medium-chain acyl-coenzyme a dehydrogenase deficiency10.0HADHA, ACADS, ACADVL, ACADL, ACADM
28brain disease10.0CPT2, ACADS, ACADM, SLC25A13
29zellweger syndrome9.9SCP2, HSD17B4
30congenital heart disease9.8PPARA, CPT1A, ACADM, SLC25A20
31adrenoleukodystrophy9.8PPARA, HSD17B4, SCP2
32myopathy9.6HADHA, PPARA, CPT1A, CPT2, ACADS, ACADVL
33hypoglycemia9.3SLC25A13, HADHA, SLC25A20, ACADM, ACADL, ACADVL
34metabolic syndrome x9.2HADHA, PPARA, CPT1A, CPT2, ACADS, ACADVL
35fatty liver disease9.1HADHA, PPARA, SCP2, CPT1A, CPT2, ACADVL

Graphical network of the top 20 diseases related to Fatty Acid Oxidation Disorders:



Diseases related to fatty acid oxidation disorders

Symptoms for Fatty Acid Oxidation Disorders

About this section

Drugs & Therapeutics for Fatty Acid Oxidation Disorders

About this section

Drug clinical trials:

Search ClinicalTrials for Fatty Acid Oxidation Disorders

Search NIH Clinical Center for Fatty Acid Oxidation Disorders

Genetic Tests for Fatty Acid Oxidation Disorders

About this section

Genetic tests related to Fatty Acid Oxidation Disorders:

id Genetic test Affiliating Genes
1 Fatty Acid Oxidation Disorders20
2 Fatty Acid Oxidation Disorders Multi-Gene Panels20

Anatomical Context for Fatty Acid Oxidation Disorders

About this section

MalaCards organs/tissues related to Fatty Acid Oxidation Disorders:

31
Liver, Skin, Whole blood, Skeletal muscle, Placenta, Testes

Animal Models for Fatty Acid Oxidation Disorders or affiliated genes

About this section

MGI Mouse Phenotypes related to Fatty Acid Oxidation Disorders:

35
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053758.3ACOT7, ACADVL, SCP2, PPARA
2MP:00053697.9HADHA, PPARA, HSD17B4, ACADS, ACADVL, ACADM
3MP:00107686.7HADHA, PPARA, HSD17B4, CPT1A, ACADS, ACADVL
4MP:00053786.7HADHA, PPARA, HSD17B4, SCP2, ACADVL, ACOT7
5MP:00053706.2SLC25A13, HADHA, PPARA, HSD17B4, SCP2, ACADS
6MP:00053765.7HADHA, PPARA, HSD17B4, SCP2, CPT1A, ACADS

Publications for Fatty Acid Oxidation Disorders

About this section

Articles related to Fatty Acid Oxidation Disorders:

(show top 50)    (show all 73)
idTitleAuthorsYear
1
Impact of fatty acid oxidation disorders in child neurology: from Reye syndrome to Pandora's box. (25761966)
2015
2
Bezafibrate in skeletal muscle fatty acid oxidation disorders: a randomized clinical trial. (24453079)
2014
3
Should the beneficial impact of bezafibrate on fatty acid oxidation disorders be questioned? (25310995)
2014
4
Muscle MRI in patients with long-chain fatty acid oxidation disorders. (24305961)
2013
5
Clinical study of organic acidemias and fatty acid oxidation disorders detected in adults. (23524598)
2013
6
Fatty Acid oxidation disorders in a chinese population in taiwan. (23700290)
2013
7
Variability in the clinical management of fatty acid oxidation disorders: results of a survey of Canadian metabolic physicians. (21630065)
2012
8
Acute fatty liver in pregnancy: revealing fetal fatty acid oxidation disorders]. (22325456)
2012
9
Rubratoxin B induces signs of fatty acid oxidation disorders (FAODs) in mice. (21835235)
2011
10
Fatty acid omega-oxidation as a rescue pathway for fatty acid oxidation disorders in humans. (21156023)
2011
11
Current issues regarding treatment of mitochondrial fatty acid oxidation disorders. (20830526)
2010
12
Mitochondrial fatty acid oxidation disorders: pathophysiological studies in mouse models. (20532823)
2010
13
Mitochondrial fatty acid oxidation disorders. Proceedings of an international symposium. October 2008. Fulda, Germany. (21275107)
2010
14
Clinical and biochemical monitoring of patients with fatty acid oxidation disorders. (20066495)
2010
15
Update on mitochondrial fatty acid oxidation disorders. (20842433)
2010
16
Pathophysiology of fatty acid oxidation disorders. (20824345)
2010
17
ESI-MS/MS measurement of free carnitine and its precursor I^-butyrobetaine in plasma and dried blood spots from patients with organic acidurias and fatty acid oxidation disorders. (20637671)
2010
18
Deuterated palmitate-driven acylcarnitine formation by whole-blood samples for a rapid diagnostic exploration of mitochondrial fatty acid oxidation disorders. (19422814)
2009
19
PPARs as therapeutic targets for correction of inborn mitochondrial fatty acid oxidation disorders. (18392740)
2008
20
3-hydroxyacyl-CoA dehydrogenase (HAD) deficiency replaces short-chain hydroxyacyl-CoA dehydrogenase (SCHAD) deficiency as well as medium- and short-chain hydroxyacyl-CoA dehydrogenase (M/SCHAD) deficiency as the consensus name of this fatty acid oxidation disorder. (17434778)
2007
21
ESI-MS/MS study of acylcarnitine profiles in urine from patients with organic acidemias and fatty acid oxidation disorders. (17301002)
2007
22
Application of tandem mass spectrometry on the diagnosis of fatty acid oxidation disorders]. (18067086)
2007
23
Differentiation of long-chain fatty acid oxidation disorders using alternative precursors and acylcarnitine profiling in fibroblasts. (16297647)
2006
24
Potential of fibrates in the treatment of fatty acid oxidation disorders: revival of classical drugs? (16763897)
2006
25
Fatty acid oxidation disorder as a cause of sudden infant death syndrome (SIDS)--a case report. (16366103)
2005
26
The association between acute fatty liver of pregnancy and fatty acid oxidation disorders. (15673650)
2005
27
Identification of fatty acid oxidation disorder patients with lowered acyl-CoA thioesterase activity in human skin fibroblasts. (15638818)
2005
28
Bezafibrate increases very-long-chain acyl-CoA dehydrogenase protein and mRNA expression in deficient fibroblasts and is a potential therapy for fatty acid oxidation disorders. (16115821)
2005
29
Human placenta metabolizes fatty acids: implications for fetal fatty acid oxidation disorders and maternal liver diseases. (12582009)
2003
30
Selective screening for fatty acid oxidation disorders by tandem mass spectrometry: difficulties in practical discrimination. (12828998)
2003
31
A method for quantitative acylcarnitine profiling in human skin fibroblasts using unlabelled palmitic acid: diagnosis of fatty acid oxidation disorders and differentiation between biochemical phenotypes of MCAD deficiency. (12385891)
2002
32
Incidence and short-term outcome of children with symptomatic presentation of organic acid and fatty acid oxidation disorders in Germany. (12456920)
2002
33
Management of fatty acid oxidation disorders: a survey of current treatment strategies. (12487544)
2002
34
Prevalent mutations in fatty acid oxidation disorders: diagnostic considerations. (11216903)
2000
35
Acylcarnitines in fibroblasts of patients with long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency and other fatty acid oxidation disorders. (10682306)
2000
36
Mitochondrial fatty acid oxidation disorders and cyclic vomiting syndrome. (10490047)
1999
37
Sudden and unexpected neonatal death: a protocol for the postmortem diagnosis of fatty acid oxidation disorders. (10331471)
1999
38
A critical role for the peroxisome proliferator-activated receptor alpha (PPARalpha) in the cellular fasting response: the PPARalpha-null mouse as a model of fatty acid oxidation disorders. (10377439)
1999
39
The use of [9,10-3H]myristate, [9,10-3H]palmitate and [9,10-3H]oleate for the detection and diagnosis of medium and long-chain fatty acid oxidation disorders in intact cultured fibroblasts. (10709659)
1999
40
Retrospective biochemical screening of fatty acid oxidation disorders in postmortem livers of 418 cases of sudden death in the first year of life. (9627580)
1998
41
Neonatal onset in fatty acid oxidation disorders: how can we minimize morbidity and mortality? (9762596)
1998
42
Analysis of carnitine esters by radio-high performance liquid chromatography in cultured skin fibroblasts from patients with mitochondrial fatty acid oxidation disorders. (9702916)
1998
43
Dissecting the spectrum of fatty acid oxidation disorders. (9544886)
1998
44
Clinical and biochemical features of fatty acid oxidation disorders. (9848022)
1998
45
Identification and quantification of intermediates of unsaturated fatty acid metabolism in plasma of patients with fatty acid oxidation disorders. (7586519)
1995
46
Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency: a severe fatty acid oxidation disorder. (7813533)
1994
47
Biochemical diagnosis of fatty acid oxidation disorders by metabolite analysis of postmortem liver. (8056418)
1994
48
New developments in the diagnosis and investigation of mitochondrial fatty acid oxidation disorders. (7957387)
1994
49
The role of tandem mass spectrometry in the diagnosis of fatty acid oxidation disorders. (1438380)
1992
50
Postmortem recognition of fatty acid oxidation disorders. (1866359)
1991

Variations for Fatty Acid Oxidation Disorders

About this section

Expression for genes affiliated with Fatty Acid Oxidation Disorders

About this section
Search GEO for disease gene expression data for Fatty Acid Oxidation Disorders.

Pathways for genes affiliated with Fatty Acid Oxidation Disorders

About this section

Pathways related to Fatty Acid Oxidation Disorders according to GeneCards Suite gene sharing:

(show all 18)
idSuper pathways (with members indented)ScoreTop Affiliating Genes
1
Show member pathways
phenylethylamine degradation I36
9.9ACADM, HADHA
2
Show member pathways
9.9HADHA, ACADM
3
Show member pathways
9.8ACADS, HADHA
4
Show member pathways
oleate biosynthesis II (animals)36
9.7ACOT7, HADHA
59.6ACADVL, CPT1A, ACADM
6
Show member pathways
L-serine degradation36
pentose phosphate pathway (oxidative branch)36
formaldehyde oxidation II (glutathione-dependent)36
9.6ACADM, HADHA, ACADS
79.5ACADM, HADHA, CPT1A
8
Show member pathways
9.5SCP2, HSD17B4
9
Show member pathways
9.5SCP2, HSD17B4
10
Show member pathways
9.5HSD17B4, SCP2
11
Show member pathways
9.3CPT1A, PPARA
12
Show member pathways
fatty acid beta-oxidation I36
eicosapentaenoate biosynthesis II (metazoa)36
gamma-linolenate biosynthesis II (animals)36
fatty acid activation36
9.2HADHA, HSD17B10, SCP2
13
Show member pathways
beta-alanine degradation I36
valine degradation I36
pyruvate fermentation to lactate36
isoleucine degradation I36
9.2ACADM, ACADS, HADHA, HSD17B10
14
Show member pathways
mitochondrial L-carnitine shuttle pathway36
Saturated fatty acid biosynthesis59
8.4ACADM, ACADL, ACADS, CPT2, CPT1A, HADHA
15
Show member pathways
fatty acid beta-oxidation III (unsaturated, odd number)36
Fatty Acid Beta Oxidation36
7.6HADHA, SLC25A20, ACADM, ACADL, ACADVL, ACADS
16
Show member pathways
fatty acid beta-oxidation VI (peroxisome)36
7.5HSD17B4, SCP2, CPT1A, CPT2, ACADM, PPARA
17
Show member pathways
7.3ACADVL, SLC25A20, ACADM, ACADL, ACADS, CPT2
18
Show member pathways
5.3SLC25A13, SCP2, CPT1A, CPT2, ACADS, ACADVL

Compounds for genes affiliated with Fatty Acid Oxidation Disorders

About this section
Sources:
24HMDB, 44Novoseek, 11DrugBank, 28IUPHAR
See all sources

Compounds related to Fatty Acid Oxidation Disorders according to GeneCards Suite gene sharing:

(show top 50)    (show all 224)
idCompoundScoreTop Affiliating Genes
1Methacrylyl-CoA249.7ACADS, HADHA, ACADM
2Tiglyl-CoA249.6ACADS, HADHA, ACADM
3acetyl-l-carnitine449.5HADHA, ACADVL, CPT1A, ACADM
42-methyl-3-hydroxybutyryl-coa44 2410.3HSD17B10, HSD17B4, HADHA
5(3S)-3-Hydroxyadipyl-CoA249.2HSD17B10, HSD17B4, HADHA
6octanoate449.0HADHA, ACADM, CPT1A, PPARA
7s-adenosylmethionine44 24 1110.7CPT1A, CPT2, ACADS, HADHA, SLC25A20, ACADM
8citrate448.5CPT1A, CPT2, HSD17B10, HADHA, PPARA
917beta-hydroxysteroid448.4SCP2, ACADS, HSD17B10, HSD17B4
10linoleic acid28 44 2410.4ACOT7, PPARA, ACADM, CPT1A, CPT2
11pristanic acid44 28 2410.4SLC25A20, ACADL, CPT2, CPT1A, SCP2, PPARA
12oleic acid44 28 24 1111.2ACOT7, CPT1A, SCP2, PPARA, ACADM
13Isobutyryl-CoA248.1ACOT7, ACADL, ACADVL, ACADS, ACADM, HADHA
14Hexanoyl-CoA248.1ACADVL, ACADM, ACOT7, ACADL, PPARA, ACADS
15Glutaconyl-CoA248.1HADHA, PPARA, ACADS, ACADVL, ACADL, ACOT7
16Butyryl-CoA248.1PPARA, ACADVL, ACADL, ACOT7, ACADM, HADHA
172-Methylhexanoyl-CoA248.1HADHA, PPARA, ACADS, ACADVL, ACADL, ACOT7
18Decanoyl-CoA (n-C10:0CoA)248.1ACADM, ACOT7, HADHA, PPARA, ACADS, ACADVL
19Undecanoyl-CoA248.1HADHA, PPARA, ACADS, ACADVL, ACADL, ACOT7
20Tetracosanoyl-CoA248.1PPARA, ACADS, ACADVL, ACADL, ACOT7, HADHA
21Pentanoyl-CoA248.1HADHA, PPARA, ACADS, ACADVL, ACADL, ACOT7
22trans-Octadec-2-enoyl-CoA248.0ACADM, ACOT7, HADHA, PPARA, ACADS, ACADVL
23Lauroyl-CoA248.0ACOT7, ACADM, ACADL, ACADVL, ACADS, HADHA
24Isovaleryl-CoA248.0HADHA, PPARA, ACADS, ACADVL, ACADL, ACOT7
25Nonanoyl-CoA248.0HADHA, PPARA, ACADS, ACADVL, ACADL, ACOT7
262-methylbutyryl-coa44 249.0ACADM, ACADL, ACADVL, PPARA, HADHA, ACOT7
27(2E)-Decenoyl-CoA248.0ACADL, ACOT7, ACADM, ACADVL, HADHA, PPARA
28Eicosanoyl-CoA248.0HADHA, PPARA, ACOT7, ACADL, ACADVL, ACADS
29octanoyl-coa44 249.0ACADVL, HADHA, PPARA, ACADM, ACOT7, ACADL
30(2E)-Dodecenoyl-CoA248.0ACADVL, ACADL, ACOT7, ACADM, HADHA, PPARA
31trans-2-Hexenoyl-CoA248.0PPARA, ACADS, ACADVL, ACADL, ACADM, ACOT7
32Pristanoyl-CoA248.0HADHA, PPARA, ACADS, ACADVL, ACADL, ACADM
33Crotonoyl-CoA248.0HADHA, ACADS, ACADM, ACOT7, ACADVL, ACADL
34(2E)-Octenoyl-CoA248.0ACADVL, ACADS, ACADL, ACOT7, ACADM, HADHA
35palmitate448.0HADHA, PPARA, SCP2, CPT1A, CPT2, ACADVL
363Z-dodecenoyl-CoA248.0PPARA, HADHA, ACADVL, ACADS, ACADL, ACADM
37Acrylyl-CoA248.0ACADM, ACOT7, ACADL, HADHA, ACADS, PPARA
38(2E)-Tetradecenoyl-CoA248.0ACADS, ACADVL, ACADL, ACADM, HADHA, PPARA
39stearoyl-coa44 249.0HADHA, PPARA, ACADS, ACADVL, ACOT7, ACADM
40(2E)-Hexadecenoyl-CoA248.0HADHA, PPARA, ACADS, ACADVL, ACADM, ACOT7
41Propionyl-CoA247.9ACADM, ACOT7, ACADL, ACADS, PPARA, HADHA
42Heptadecanoyl CoA247.9ACADVL, ACADM, HADHA, ACOT7, PPARA, ACADS
43carnitine447.7SLC25A20, ACADM, ACADL, ACADVL, ACADS, CPT2
44glutamate447.5SLC25A13, CPT2, HSD17B10, ACADS, ACADM, PPARA
45Palmityl-CoA247.5PPARA, CPT1A, CPT2, ACADM, ACOT7, ACADS
46Heptanoyl-CoA247.2HADHA, PPARA, ACADM, ACOT7, ACADL, ACADVL
47acetyl-coa44 248.0ACOT7, ACADM, ACADL, CPT2, CPT1A, SCP2
48lipid446.6PPARA, HSD17B10, SCP2, HADHA, ACADL, CPT1A
49acyl-coa445.8SLC25A20, PPARA, HADHA, HSD17B4, HSD17B10, ACADM
50fatty acid445.2HADHA, PPARA, HSD17B4, HSD17B10, SCP2, CPT1A

GO Terms for genes affiliated with Fatty Acid Oxidation Disorders

About this section

Cellular components related to Fatty Acid Oxidation Disorders according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1mitochondrial nucleoidGO:00426459.9ACADVL, HADHA
2peroxisomal matrixGO:00057829.2SCP2, HSD17B4
3mitochondrial matrixGO:00057598.8HSD17B10, ACADS, ACADVL, ACADL, ACADM
4mitochondrial inner membraneGO:00057438.0HADHA, HSD17B10, CPT1A, CPT2, ACADVL, SLC25A20
5mitochondrionGO:00057395.6SLC25A13, HADHA, HSD17B4, HSD17B10, SCP2, CPT1A

Biological processes related to Fatty Acid Oxidation Disorders according to GeneCards Suite gene sharing:

(show all 18)
idNameGO IDScoreTop Affiliating Genes
1carnitine metabolic process, CoA-linkedGO:001925410.2ACADM, ACADL
2negative regulation of fatty acid oxidationGO:004632210.2ACADVL, ACADL
3regulation of cholesterol metabolic processGO:009018110.1ACADL, ACADVL
4negative regulation of fatty acid biosynthetic processGO:004571710.1ACADL, ACADVL
5temperature homeostasisGO:00016599.9ACADVL, ACADL
6carnitine shuttleGO:00068539.9SLC25A20, CPT1A, CPT2
7fatty acid beta-oxidation using acyl-CoA oxidaseGO:00335409.7SCP2, HSD17B4
8unsaturated fatty acid metabolic processGO:00335599.6SCP2, HSD17B4
9alpha-linolenic acid metabolic processGO:00361099.6SCP2, HSD17B4
10fatty acid beta-oxidation using acyl-CoA dehydrogenaseGO:00335399.6ACADL, ACADS, ACADVL, ACADM
11response to starvationGO:00425949.6ACADS, ACADM
12oxidation-reduction processGO:00551149.5HSD17B4, ACADL, ACADM
13positive regulation of fatty acid beta-oxidationGO:00320009.5CPT1A, PPARA
14bile acid metabolic processGO:00082069.5SCP2, HSD17B4
15bile acid biosynthetic processGO:00066999.4SCP2, HSD17B4
16fatty acid beta-oxidationGO:00066358.2HSD17B4, ACADVL, HADHA, ACADM, CPT1A, CPT2
17cellular lipid metabolic processGO:00442556.6HADHA, CPT2, HSD17B4, ACADM, ACADL, ACADVL
18small molecule metabolic processGO:00442815.6SCP2, CPT2, ACADS, ACADVL, ACADL, ACADM

Molecular functions related to Fatty Acid Oxidation Disorders according to GeneCards Suite gene sharing:

(show all 8)
idNameGO IDScoreTop Affiliating Genes
1long-chain-acyl-CoA dehydrogenase activityGO:00044669.8ACADVL, ACADL
2long-chain-enoyl-CoA hydratase activityGO:00165089.7HADHA, HSD17B4
33-hydroxyacyl-CoA dehydrogenase activityGO:00038579.7HSD17B4, HADHA
4carnitine O-palmitoyltransferase activityGO:00040959.6CPT2, CPT1A
5long-chain fatty acyl-CoA bindingGO:00360429.5ACOT7, SCP2
6acyl-CoA dehydrogenase activityGO:00039959.4ACADS, ACADVL, ACADL, ACADM
7flavin adenine dinucleotide bindingGO:00506609.4ACADS, ACADVL, ACADL, ACADM
8fatty-acyl-CoA bindingGO:00000628.6ACOT7, ACADL, ACADS, SCP2, HADHA

Sources for Fatty Acid Oxidation Disorders

About this section
2CDC
12ExPASy
13FDA
14FMA
22GTR
23HGMD
24HMDB
25ICD10
26ICD10 via Orphanet
27ICD9CM
28IUPHAR
29KEGG
33MeSH
34MESH via Orphanet
35MGI
38NCI
39NCIt
40NDF-RT
43NINDS
44Novoseek
46OMIM
47OMIM via Orphanet
51PubMed
52QIAGEN
57SNOMED-CT via Orphanet
61UMLS
62UMLS via Orphanet